Literature DB >> 23358926

TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells.

Zhang Peng1, Yue Shuangzhu, Jiang Yongjie, Zhang Xinjun, Liu Ying.   

Abstract

Tumor necrosis factor receptor-associated factor 6 (TRAF6), which plays an important role in inflammation and immune response, is an essential adaptor protein for the NF-κB (nuclear factor κB) signaling pathway. Recent studies have shown that TRAF6 played an important role in tumorigenesis and invasion by suppressing NF-κB activation. However, up to now, the biologic role of TRAF6 in glioma has still remained unknown. To address the expression of TRAF6 in glioma cells, four glioma cell lines (U251, U-87MG, LN-18, and U373) and a non-cancerous human glial cell line SVG p12 were used to explore the protein expression of TRAF6 by Western blot. Our results indicated that TRAF6 expression was upregulated in human glioma cell lines, especially in metastatic cell lines. To investigate the role of TRAF6 in cell proliferation, apoptosis, invasion, and migration of glioma, we generated human glioma U-87MG cell lines in which TRAF6 was either overexpressed or depleted. Subsequently, the effects of TRAF6 on cell viability, cell cycle distribution, apoptosis, invasion, and migration in U-87MG cells were determined with 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide (MTT) assay, flow cytometry analysis, transwell invasion assay, and wound-healing assay. The results showed that knockdown of TRAF6 could decrease cell viability, suppress cell proliferation, invasion and migration, and promote cell apoptosis, whereas overexpression of TRAF6 displayed the opposite effects. In addition, the effects of TRAF6 on the expression of phosphor-NF-κB (p-p65), cyclin D1, caspase 3, and MMP-9 were also probed. Knockdown of TRAF6 could lower the expression of p-p65, cyclin D1, and MMP-9, and raise the expression of caspase 3. All these results suggested that TRAF6 might be involved in the potentiation of growth, proliferation, invasion, and migration of U-87MG cell, as well as inhibition of apoptosis of U-87MG cell by abrogating activation of NF-κB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358926     DOI: 10.1007/s11010-013-1573-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

Review 1.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

2.  Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis.

Authors:  Toshihiro Inubushi; Aki Kawazoe; Mutsumi Miyauchi; Yasusei Kudo; Min Ao; Atsushi Ishikado; Taketoshi Makino; Takashi Takata
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

Review 3.  Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Authors:  Kian-Huat Lim; Yibin Yang; Louis M Staudt
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

4.  Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method.

Authors:  Jerzy Walecki; Eugeniusz Tarasów; Bozena Kubas; Zbigniew Czemicki; Janusz Lewko; Jan Podgórski; Maria Sokól; Pawel Grieb
Journal:  Acad Radiol       Date:  2003-02       Impact factor: 3.173

5.  MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.

Authors:  Hui-Ju Wang; Hong-Jun Ruan; Xu-Jun He; Ying-Yu Ma; Xiao-Ting Jiang; Ying-Jie Xia; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Eur J Cancer       Date:  2010-08       Impact factor: 9.162

6.  Identification of a novel blocker of IkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB.

Authors:  Bokyung Sung; Manoj K Pandey; Yuki Nakajima; Hiroshi Nishida; Tetsuya Konishi; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Mol Cancer Ther       Date:  2008-01       Impact factor: 6.261

7.  Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells.

Authors:  Li Jia; Ganga Gopinathan; Johanna T Sukumar; John G Gribben
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.

Authors:  Hong Ri Jin; Song Zhu Jin; Xing Fu Cai; Donghao Li; Xue Wu; Ji Xing Nan; Jung Joon Lee; Xuejun Jin
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation.

Authors:  Tao Tao; Chun Cheng; Yuhong Ji; Guangfei Xu; Jianguo Zhang; Li Zhang; Aiguo Shen
Journal:  Mol Biol Cell       Date:  2012-05-16       Impact factor: 4.138

10.  TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.

Authors:  Matthew C Walsh; Gregory K Kim; Paul L Maurizio; Elizabeth E Molnar; Yongwon Choi
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more
  11 in total

1.  EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.

Authors:  Haizhong Feng; Giselle Y Lopez; Chung Kwon Kim; Angel Alvarez; Christopher G Duncan; Ryo Nishikawa; Motoo Nagane; An-Jey A Su; Philip E Auron; Matthew L Hedberg; Lin Wang; Jeffery J Raizer; John A Kessler; Andrew T Parsa; Wei-Qiang Gao; Sung-Hak Kim; Mutsuko Minata; Ichiro Nakano; Jennifer R Grandis; Roger E McLendon; Darell D Bigner; Hui-Kuan Lin; Frank B Furnari; Webster K Cavenee; Bo Hu; Hai Yan; Shi-Yuan Cheng
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

2.  Modified Genomic Self-DNA Influences In Vitro Survival of HT29 Tumor Cells via TLR9- and Autophagy Signaling.

Authors:  Ferenc Sipos; Anna L Kiss; Miklós Constantinovits; Zsolt Tulassay; Györgyi Műzes
Journal:  Pathol Oncol Res       Date:  2018-11-21       Impact factor: 3.201

3.  Regulatory effects of AT₁R-TRAF6-MAPKs signaling on proliferation of intermittent hypoxia-induced human umbilical vein endothelial cells.

Authors:  Jin Shang; Xue-Ling Guo; Yan Deng; Xiao Yuan; Hui-Guo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

4.  Dynamic expression of miR-132, miR-212, and miR-146 in the brain of different hosts infected with Angiostrongylus cantonensis.

Authors:  Liping Yu; Qi Liao; Xiaoguang Chen; Lian Xu; Xin Zeng; Zhiyue Lv; Xi Sun; Huanqin Zhen; Zhongdao Wu
Journal:  Parasitol Res       Date:  2013-10-19       Impact factor: 2.289

Review 5.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

6.  Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study.

Authors:  Jian-Jun Li; Jie Luo; Jing-Ning Lu; Xiao-Na Liang; Yi-Huan Luo; Yong-Ru Liu; Jie Yang; Hua Ding; Gui-Hui Qin; Li-Hua Yang; Yi-Wu Dang; Hong Yang; Gang Chen
Journal:  Cancer Cell Int       Date:  2016-09-29       Impact factor: 5.722

7.  Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6.

Authors:  Yonghao Qi; Ambara R Pradipta; Miao Li; Xuan Zhao; Lulu Lu; Xuegang Fu; Jing Wei; Richard P Hsung; Katsunori Tanaka; Lijun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2017-02-23

Review 8.  Mechanism by which TRAF6 Participates in the Immune Regulation of Autoimmune Diseases and Cancer.

Authors:  Jingjing Wang; Xinjie Wu; Mengyu Jiang; Guixiang Tai
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

9.  siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.

Authors:  Zhiyong He; Chuanzhong Huang; Gen Lin; Yunbin Ye
Journal:  Oncol Rep       Date:  2016-02-01       Impact factor: 3.906

10.  TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.

Authors:  Lei Chen; Yi-Cun Li; Lei Wu; Guang-Tao Yu; Wen-Feng Zhang; Cong-Fa Huang; Zhi-Jun Sun
Journal:  J Cell Mol Med       Date:  2017-11-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.